Parcourir par auteur "Skarlatos, J."
Voici les éléments 1-4 de 4
-
Clinical and experimental evidence of bcl-2 involvement in the response to photodynamic therapy
Koukourakis, M. I.; Corti, L.; Skarlatos, J.; Giatromanolaki, A.; Krammer, B.; Blandamura, S.; Piazza, M.; Verwanger, T.; Schnitzhofer, G.; Kostandelos, J.; Beroukas, K. (2001)Purpose: The role of apoptosis related proteins in the response of human malignancies to photodynamic therapy (PDT) is under investigation. The aim of the study was to examine the role of p53 and of bcl-2 protein expression ... -
Hidradenocarcinoma of the temporal area successfully treated with concomitant electrochemotherapy and radiotherapy
Kyrgias, G.; Kostopoulou, E.; Zafiriou, E.; Skarlatos, J.; Theodorou, K. (2013)Hidradenocarcinoma, the malignant counterpart of hidradenoma, is an extremely rare malignant tumour which may exhibit an aggressive clinical course. The standard primary treatment is wide local excision with or without ... -
Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy
Koukourakis, M. I.; Giatromanolaki, A.; Skarlatos, J.; Corti, L.; Blandamura, S.; Piazza, M.; Gatter, K. C.; Harris, A. L. (2001)Hypoxia inducible factor 1a and 2a (HIF-1a and HIF-2a) are key proteins regulating cellular response to hypoxia, Because the efficacy of photodynamic therapy (PDT) is dependent on the presence of oxygen, the assessment of ... -
Intraoperative radiation therapy on pancreatic cancer patients: a review of the literature
Zygogianni, G. A.; Kyrgias, G.; Kouvaris, J.; Antypas, C.; Skarlatos, J.; Armpilia, C.; Nikiteas, N.; Kouloulias, E. V. (2011)Pancreatic cancer is rarely curable, and the overall survival rate at 5 years is under 4%. This study aimed to assess the efficacy, effectiveness and safety of intraoperative radiation therapy (IORT) as treatment in ...